343 related articles for article (PubMed ID: 12134237)
21. Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma.
Bossolasco S; Cinque P; Ponzoni M; Vigano MG; Lazzarin A; Linde A; Falk KI
J Neurovirol; 2002 Oct; 8(5):432-8. PubMed ID: 12402169
[TBL] [Abstract][Full Text] [Related]
22. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
23. Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas.
Martini M; Capello D; Serraino D; Navarra A; Pierconti F; Cenci T; Gaidano G; Larocca LM
J Infect; 2007 Mar; 54(3):298-306. PubMed ID: 16784778
[TBL] [Abstract][Full Text] [Related]
24. [Sequences of human herpes virus type 8 and Epstein-Barr virus in AIDS-related primary central nervous system non-Hodgkin's lymphoma].
Bélec L; Wingertsmann L; Chrétien F; Mohamed AS; Minarovits J; Gray F
Arch Anat Cytol Pathol; 1997; 45(2-3):159-63. PubMed ID: 9382608
[TBL] [Abstract][Full Text] [Related]
25. [AIDS related lymphomas: Histopathological subtypes and association with Epstein Barr virus and Human Herpes virus type-8].
Corti M; de Dios Soler M; Bare P; Villafañe MF; De Tezanos Pinto M; Perez Bianco R; Narbaitz M
Medicina (B Aires); 2010; 70(2):151-8. PubMed ID: 20447898
[TBL] [Abstract][Full Text] [Related]
26. A longitudinal and cross-sectional study ofEpstein-Barr virus DNA load: a possible predictor of AIDS-related lymphoma in HIV-infected patients.
Hijlkema SH; van Kampen JJA; Voermans JJC; den Oudsten MYE; Doorduijn J; van Lugtenburg PJ; van de Vijver DAMC; van der Ende ME
Infect Dis (Lond); 2018; 50(11-12):847-852. PubMed ID: 30317893
[TBL] [Abstract][Full Text] [Related]
27. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
[TBL] [Abstract][Full Text] [Related]
28. The significance of Epstein-Barr virus detected in the cerebrospinal fluid of people with HIV infection.
Wang J; Ozzard A; Nathan M; Atkins M; Nelson M; Gazzard B; Bower M
HIV Med; 2007 Jul; 8(5):306-11. PubMed ID: 17561877
[TBL] [Abstract][Full Text] [Related]
29. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.
Bauer CC; Aberle SW; Popow-Kraupp T; Kapitan M; Hofmann H; Puchhammer-Stöckl E
J Med Virol; 2005 Jan; 75(1):54-8. PubMed ID: 15543583
[TBL] [Abstract][Full Text] [Related]
30. Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: reliable markers for individual strain identification.
Berger C; van Baarle D; Kersten MJ; Klein MR; Al-Homsi AS; Dunn B; McQuain C; van Oers R; Knecht H
J Infect Dis; 1999 Jan; 179(1):240-4. PubMed ID: 9841847
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction.
Balandraud N; Meynard JB; Auger I; Sovran H; Mugnier B; Reviron D; Roudier J; Roudier C
Arthritis Rheum; 2003 May; 48(5):1223-8. PubMed ID: 12746895
[TBL] [Abstract][Full Text] [Related]
32. Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen.
Stevens SJ; Pronk I; Middeldorp JM
J Clin Microbiol; 2001 Apr; 39(4):1211-6. PubMed ID: 11283029
[TBL] [Abstract][Full Text] [Related]
33. Persistent infection by HCV and EBV in peripheral blood mononuclear cells and risk of non-Hodgkin's lymphoma.
Richiardi L; De Marco L; Gillio-Tos A; Merletti F; Fiano V; Palli D; Masala G; Agnoli C; Tagliabue G; Panico S; Mattiello A; Tumino R; Frasca G; Vineis P; Sacerdote C
Cancer Epidemiol; 2010 Dec; 34(6):709-12. PubMed ID: 20709616
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of plasma Epstein-Barr virus DNA load as a prognostic marker for nasopharyngeal carcinoma.
Tan EL; Looi LM; Sam CK
Singapore Med J; 2006 Sep; 47(9):803-7. PubMed ID: 16924363
[TBL] [Abstract][Full Text] [Related]
35. Aggressive forms of non-Hodgkin's lymphoma in two patients bearing coinfection of Epstein-Barr and hepatitis C viruses.
Libra M; Gloghini A; De Re V; Rupolo M; Navolanic PM; Gasparotto D; Stivala F; Spina M; Boiocchi M; Carbone A
Int J Oncol; 2005 Apr; 26(4):945-50. PubMed ID: 15753988
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas.
Cingolani A; Gastaldi R; Fassone L; Pierconti F; Giancola ML; Martini M; De Luca A; Ammassari A; Mazzone C; Pescarmona E; Gaidano G; Larocca LM; Antinori A
J Clin Oncol; 2000 Oct; 18(19):3325-30. PubMed ID: 11013271
[TBL] [Abstract][Full Text] [Related]
37. Relationship between non-Hodgkin's lymphoma and blood levels of Epstein-Barr virus in children in north-western Tanzania: a case control study.
Kabyemera R; Masalu N; Rambau P; Kamugisha E; Kidenya B; De Rossi A; Petrara MR; Mwizamuholya D
BMC Pediatr; 2013 Jan; 13():4. PubMed ID: 23294539
[TBL] [Abstract][Full Text] [Related]
38. Immortalized Epstein-Barr virus-positive B-cell lines obtained by prolonged culture of peripheral blood mononuclear cells from human immunodeficiency virus type 1-positive patients.
Ruibal-Ares B; Belmonte L; Baré P; Scolnik M; Palacios MF; Bayo-Hanza C; Galmarini CM; Mendez G; de Bracco MM
J Hum Virol; 2001; 4(4):200-13. PubMed ID: 11694848
[TBL] [Abstract][Full Text] [Related]
39. Serum sCD23 level in patients with AIDS-related non-Hodgkin's lymphoma is associated with absence of Epstein-Barr virus in tumor tissue.
Schroeder JR; Saah AJ; Ambinder RF; Martinez-Maza O; Crabb Breen E; Variakojis D; Margolick JB; Jacobson LP; Rowe DT; Hoover DR
Clin Immunol; 1999 Dec; 93(3):239-44. PubMed ID: 10600334
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus genome load is increased by therapeutic vaccination in HIV-l carriers, and further enhanced in patients with a history of symptomatic primary infection.
Friis AM; Akerlund B; Gyllensten K; Aleman A; Bratt G; Sandström E; Ernberg I
Vaccine; 2012 Sep; 30(42):6093-8. PubMed ID: 22863659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
